Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile dysfunction. An update].

G Wagner1, I Saenz de Tejada

  • 1Københavns Universitet, Panum Instituttet.

Ugeskrift for Laeger
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction affects 10% of men aged 40-70, yet few seek help. Increased awareness and education for doctors and the public are crucial for better management of erectile dysfunction and its treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Reactions of 4-oxo-4H-pyrido(3',2':4,5)thieno(3,2-d)-1,3-oxazines with amines].

Die Pharmazie·1992
Same author

[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)amidines by means of reaction of 4-oxo-4H-pyrido(3',2':4,5)thieno(3,2-d)-1,3-oxazines with primary aliphatic amines].

Die Pharmazie·1992
Same author

Effects of DNA binding and metal substitution on the dynamics of the GAL4 DNA-binding domain as studied by amide proton exchange.

Protein science : a publication of the Protein Society·1992
Same author

Comparison of the NMR solution structure and the x-ray crystal structure of rat metallothionein-2.

Proceedings of the National Academy of Sciences of the United States of America·1992
Same author

Partial nucleotide sequence of phytochrome from the zygnematophycean green alga Mougeotia.

Photochemistry and photobiology·1992
Same author

[Synthesis of N-(2-carboxy-thieno(2,3-b)pyridin-3-yl)-amidines by the reaction with 4-oxo-4H-pyrido(3',2':4,5)-thieno(3,2-d)-1,3-oxazines with secondary cycloaliphatic amines].

Die Pharmazie·1992
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Context:

  • Erectile dysfunction (ED) affects approximately 10% of men aged 40-70.
  • ED is often linked to systemic diseases and surgical interventions.
  • A significant gap exists between ED prevalence and medical help-seeking behavior.

Purpose:

  • To highlight the prevalence of erectile dysfunction.
  • To emphasize the association of ED with other health conditions.
  • To advocate for increased awareness and education among healthcare providers and the public regarding ED and its management.

Summary:

  • Discusses the underdiagnosis and undertreatment of erectile dysfunction (ED).
  • Details current therapeutic options including counseling, devices, and drug delivery systems.

Related Experiment Videos

  • Mentions ongoing research into novel oral treatments for ED.

    • Impact:

    • Aims to improve patient outcomes by encouraging earlier medical consultation.
    • Stresses the importance of a multidisciplinary approach involving various medical specialists.
    • Underscores the need for public health initiatives to destigmatize ED and promote seeking treatment.